Market News AIOpen the app

KYMR stock news · Kymera Therapeutics, Inc.

Stories about Kymera Therapeutics, Inc. (KYMR) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for KYMR

Follow Kymera Therapeutics, Inc. (KYMR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for KYMR
Free on the App Store and Google Play, or on the web.
  1. Nov 20, 2026, 6:04 PM ET · Market

    Kymera Therapeutics will share results from its KT-621 trial for skin treatment on November 23, 2026.

    Neutral

    Kymera scheduled BROADEN2 Phase 2b results for November 23, 2026. No trial findings were announced, so this update does not change the outlook for KYMR.